| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |